• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (BASD) -3006260740 POWERPORT ISP M.R.I. IMPLANTABLE PORT, CHRONOFLEX SINGLE-LUMEN, 8F; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (BASD) -3006260740 POWERPORT ISP M.R.I. IMPLANTABLE PORT, CHRONOFLEX SINGLE-LUMEN, 8F; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR Back to Search Results
Catalog Number 1808060
Device Problems Expulsion (2933); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Unspecified Infection (1930); Thrombosis/Thrombus (4440)
Event Date 03/24/2023
Event Type  Injury  
Manufacturer Narrative
H10: as the lot number for the device was not provided, a review of the device history records could not be performed.The sample was not returned to the manufacturer for inspection/evaluation.Therefore, the investigation of the reported event is inconclusive.Based upon the available information, the definitive root cause for this event is unknown.The instructions for use (ifu) is adequate for the reported device/patient code(s) and provides general instructions for use, as well as warnings, precautions and potential complications associated with the device.Upon receipt of new or additional information, a follow-up report will be submitted as applicable.H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.H3 other text : device not returned.
 
Event Description
It was reported through the litigation process that sometime post a port placement, the patient allegedly experienced infection.It was further reported that the patient allegedly developed with thrombosis.The current status of the patient is unknown.
 
Manufacturer Narrative
H10: manufacturing review: a manufacturing review was not required as this is the only complaint reported to date for this product and lot.Investigation summary: the physical device was not returned for evaluation.The medical records allege that, for a patient bard powerport isp mri port was implanted for cancer treatment.Blunt dissection was used to create a subcutaneous pocket for the port reservoir.A metal tunneler was then utilized to tunnel the port catheter from the subcutaneous pocket to the neck venotomy site.The port catheter was connected to the reservoir and it was checked for leakage.The port pocket was then irrigated and the port reservoir was placed into the pocket.The catheter was then cut to length.A peel away sheath was then placed over wire under fluoroscopic visualization.The port catheter was then placed to the peel-away sheath and positioned with the tip of the catheter at the level of superior vena cava/right atrium junction.The port catheter has a smooth course.The port reservoir was checked and subsequently flushed with heparin.The skin was closed.The patient tolerated the procedure without difficulty and remained in stable condition.The port-a-catheter was ready for use.Approximately one year after dye flow study under fluoroscopy was performed.The patient¿s port was injected with contrast and multiple spot images were obtained.Impression included moderate-sized fibrin sheath with contrast pooling at the distal aspect of the catheter raising concern for some underlying nonocclusive thrombus.After two months, computed tomography chest, abdomen and pelvis with contrast showed possible thrombus in the right internal jugular vein adjacent to the port-a-cath.Six months fourteen days later, removal of port was performed due to eroded port.Using blunt dissection the chest port was freed from adhesions and removed along with the entire tunneled venous catheter.The procedure was completed without any apparent complication.Successful removal of chest port and tunneled catheter with small purulent pocket beneath the port.Based on the medical review the reported port eroded confirmed by the investigation.Additionally, it can be confirmed that the patient experienced thrombosis and infection.However, the relationship to the port is unknown.Furthermore, the clinical condition alleged in the complaint cannot be confirmed.Based upon the available information, the definitive root cause is unknown.Labeling review: as the reported event did not allege a labeling or use related issue, a labeling review is not required.H10: d4 (expiry date: 12/2022), g2, g3, h6 (method).H11: b3, b5, d4 (medical device lot number), h6 (device, result).H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event Description
It was reported through the litigation process that one year, one month and fourteen days post a port placement via the internal jugular vein, the patient allegedly developed infection.It was further reported that the patient allegedly experience thrombosis in the right internal jugular vein adjacent to the port.Furthermore, the port was allegedly found to be eroded and was removed from the patient.The current status of the patient is unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
POWERPORT ISP M.R.I. IMPLANTABLE PORT, CHRONOFLEX SINGLE-LUMEN, 8F
Type of Device
PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR
Manufacturer (Section D)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city 84116
Manufacturer (Section G)
BARD REYNOSA S.A. DE C.V. -9617592
blvd. montebello #1
parque industrial colonial
reynosa, tamaulipas 88780
MX   88780
Manufacturer Contact
brett curtice
800 w. rio salado pkwy
tempe, AZ 85281
4803032689
MDR Report Key19095187
MDR Text Key339988695
Report Number3006260740-2024-01696
Device Sequence Number1
Product Code LJT
UDI-Device Identifier00801741027031
UDI-Public(01)00801741027031
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K063377
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Consumer,Health Professional
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 05/09/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number1808060
Device Lot NumberREFV3937
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 03/22/2024
Initial Date FDA Received04/12/2024
Supplement Dates Manufacturer Received05/06/2024
Supplement Dates FDA Received05/28/2024
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age52 YR
Patient SexFemale
-
-